S&P 500   5,254.35 (+0.11%)
DOW   39,807.37 (+0.12%)
QQQ   444.01 (-0.18%)
AAPL   171.48 (-1.06%)
MSFT   420.72 (-0.17%)
META   485.58 (-1.68%)
GOOGL   150.93 (+0.04%)
AMZN   180.38 (+0.31%)
TSLA   175.79 (-2.25%)
NVDA   903.56 (+0.12%)
NIO   4.50 (-3.64%)
AMD   180.49 (+0.50%)
BABA   72.36 (+1.08%)
T   17.60 (+0.28%)
F   13.28 (+1.68%)
MU   117.89 (-1.14%)
CGC   8.63 (-9.63%)
GE   175.53 (-2.55%)
DIS   122.36 (+1.14%)
AMC   3.72 (-14.29%)
PFE   27.75 (-0.11%)
PYPL   66.99 (+0.63%)
XOM   116.24 (+1.10%)
S&P 500   5,254.35 (+0.11%)
DOW   39,807.37 (+0.12%)
QQQ   444.01 (-0.18%)
AAPL   171.48 (-1.06%)
MSFT   420.72 (-0.17%)
META   485.58 (-1.68%)
GOOGL   150.93 (+0.04%)
AMZN   180.38 (+0.31%)
TSLA   175.79 (-2.25%)
NVDA   903.56 (+0.12%)
NIO   4.50 (-3.64%)
AMD   180.49 (+0.50%)
BABA   72.36 (+1.08%)
T   17.60 (+0.28%)
F   13.28 (+1.68%)
MU   117.89 (-1.14%)
CGC   8.63 (-9.63%)
GE   175.53 (-2.55%)
DIS   122.36 (+1.14%)
AMC   3.72 (-14.29%)
PFE   27.75 (-0.11%)
PYPL   66.99 (+0.63%)
XOM   116.24 (+1.10%)
S&P 500   5,254.35 (+0.11%)
DOW   39,807.37 (+0.12%)
QQQ   444.01 (-0.18%)
AAPL   171.48 (-1.06%)
MSFT   420.72 (-0.17%)
META   485.58 (-1.68%)
GOOGL   150.93 (+0.04%)
AMZN   180.38 (+0.31%)
TSLA   175.79 (-2.25%)
NVDA   903.56 (+0.12%)
NIO   4.50 (-3.64%)
AMD   180.49 (+0.50%)
BABA   72.36 (+1.08%)
T   17.60 (+0.28%)
F   13.28 (+1.68%)
MU   117.89 (-1.14%)
CGC   8.63 (-9.63%)
GE   175.53 (-2.55%)
DIS   122.36 (+1.14%)
AMC   3.72 (-14.29%)
PFE   27.75 (-0.11%)
PYPL   66.99 (+0.63%)
XOM   116.24 (+1.10%)
S&P 500   5,254.35 (+0.11%)
DOW   39,807.37 (+0.12%)
QQQ   444.01 (-0.18%)
AAPL   171.48 (-1.06%)
MSFT   420.72 (-0.17%)
META   485.58 (-1.68%)
GOOGL   150.93 (+0.04%)
AMZN   180.38 (+0.31%)
TSLA   175.79 (-2.25%)
NVDA   903.56 (+0.12%)
NIO   4.50 (-3.64%)
AMD   180.49 (+0.50%)
BABA   72.36 (+1.08%)
T   17.60 (+0.28%)
F   13.28 (+1.68%)
MU   117.89 (-1.14%)
CGC   8.63 (-9.63%)
GE   175.53 (-2.55%)
DIS   122.36 (+1.14%)
AMC   3.72 (-14.29%)
PFE   27.75 (-0.11%)
PYPL   66.99 (+0.63%)
XOM   116.24 (+1.10%)
NYSE:RELX

Relx (RELX) Stock Price, News & Analysis

$43.29
-0.12 (-0.28%)
(As of 04:10 PM ET)
Today's Range
$43.28
$43.54
50-Day Range
$40.82
$44.65
52-Week Range
$30.10
$44.75
Volume
830,486 shs
Average Volume
983,258 shs
Market Capitalization
$81.50 billion
P/E Ratio
N/A
Dividend Yield
0.97%
Price Target
N/A

Relx MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.15% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
-0.24mentions of Relx in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
11.46%
From $1.57 to $1.75 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.38 out of 5 stars

Computer And Technology Sector

563rd out of 587 stocks

Business Services, Not Elsewhere Classified Industry

86th out of 90 stocks

RELX stock logo

About Relx Stock (NYSE:RELX)

RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Scientific, Technical & Medical segment provides information and data sets that help researchers and healthcare professionals to advance science and health outcomes. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as increases the productivity. The Exhibitions segment is involved in the business that combines face-to-face with data and digital tools to help customers learn about markets, source products, and complete transactions. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.

RELX Stock Price History

RELX Stock News Headlines

Investors Alert: The Next Big Thing in Weight Loss
History shows biotech breakthroughs like this can turn small investments into staggering fortunes for those with the foresight to get in early. I've isolated the small company behind it all...
Relx (NYSE:RELX) Upgraded to Buy by StockNews.com
Investors Alert: The Next Big Thing in Weight Loss
History shows biotech breakthroughs like this can turn small investments into staggering fortunes for those with the foresight to get in early. I've isolated the small company behind it all...
This little-known FTSE 100 stock is my top AI pick
7 Terrific Tech Stocks to Buy Instead of the Magnificent 7
RELX: No Surprises
RELX PLC (NYSE:RELX) Q4 2023 Earnings Call Transcript
Relx raises dividend after AI demand soars
See More Headlines
Receive RELX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Relx and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
3/28/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Business services, not elsewhere classified
Sub-Industry
N/A
Employees
36,500
Year Founded
1993

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$9.91 billion
Cash Flow
$1.78 per share
Book Value
$2.27 per share

Miscellaneous

Outstanding Shares
1,882,650,000
Free Float
1,882,083,000
Market Cap
$81.86 billion
Optionable
Optionable
Beta
0.83

Social Links

Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Erik Engstrom M.Sc Econ (Age 61)
    M.Sc Eng., MBA, CEO & Executive Director
    Comp: $5.11M
  • Mr. Nicholas Lawrence LuffMr. Nicholas Lawrence Luff (Age 57)
    CFO & Executive Director
    Comp: $2.97M
  • Ms. Kumsal Bayazit Besson (Age 50)
    Chief Executive Officer of Scientific, Technical & Medical
  • Mr. Colin Tennant
    Head of Investor Relations
  • Mr. Henry Adam Udow (Age 66)
    Chief Legal Officer & Company Secretary
  • Mr. Paul Abrahams
    Head of Corporate Communications
  • Ms. Rosemary Thomson (Age 55)
    Chief Human Resources Officer
  • Mr. Mark Kelsey
    Chief Executive Officer of Risk
  • Ms. Jelena Sevo
    Chief Strategy Officer
  • Mr. Michael Walsh
    Chief Executive Officer of Legal

Should I Buy Relx Stock? RELX Pros and Cons Explained

These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Relx was last updated on Tuesday, March 26, 2024 at 10:11 PM.

Pros

Here are some ways that investors could benefit from investing in Relx Plc:

  • Relx Plc has shown consistent growth in its stock price, with a 12-month high of $44.75.
  • Relx recently increased its Semi-Annual dividend, providing investors with a higher yield compared to the previous dividend.
  • Several institutional investors, including Acadian Asset Management LLC and Janiczek Wealth Management LLC, have been increasing their holdings in Relx, indicating confidence in the company's future performance.
  • StockNews.com upgraded Relx from a "hold" rating to a "buy" rating, suggesting positive sentiment and potential future growth.
  • Relx has a strong financial position with a debt-to-equity ratio of 1.51, indicating a balanced approach to financing operations.

Cons

Investors should be bearish about investing in Relx Plc for these reasons:

  • Some analysts, such as Berenberg Bank and StockNews.com, have downgraded Relx from a "buy" rating to a "hold" rating, signaling potential concerns about future performance.
  • Northern Trust Corp reduced its position in Relx by 6.5% during the third quarter, which could indicate a lack of confidence in the company's short-term prospects.
  • Relx's quick ratio of 0.47 and current ratio of 0.52 may raise concerns about the company's liquidity and ability to meet short-term obligations.
  • While Relx has shown growth, the stock price volatility may pose a risk to investors seeking stable returns.
  • Investors should carefully monitor any further analyst ratings changes and institutional investor actions to assess the ongoing sentiment towards Relx.

RELX Stock Analysis - Frequently Asked Questions

Should I buy or sell Relx stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Relx in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" RELX shares.
View RELX analyst ratings
or view top-rated stocks.

How have RELX shares performed in 2024?

Relx's stock was trading at $39.66 at the beginning of 2024. Since then, RELX shares have increased by 9.3% and is now trading at $43.36.
View the best growth stocks for 2024 here
.

Are investors shorting Relx?

Relx saw a increase in short interest in February. As of February 15th, there was short interest totaling 2,840,000 shares, an increase of 37.9% from the January 31st total of 2,060,000 shares. Based on an average trading volume of 922,600 shares, the short-interest ratio is presently 3.1 days. Currently, 0.2% of the company's stock are sold short.
View Relx's Short Interest
.

How often does Relx pay dividends? What is the dividend yield for Relx?

Relx announced a Semi-Annual dividend on Thursday, February 15th. Investors of record on Friday, May 3rd will be given a dividend of $0.526 per share on Tuesday, June 18th. This represents a yield of 1.7%. The ex-dividend date is Thursday, May 2nd. This is a boost from the stock's previous Semi-Annual dividend of $0.22.
Read our dividend analysis for RELX
.

Is Relx a good dividend stock?

Relx (NYSE:RELX) pays an annual dividend of $0.42 per share and currently has a dividend yield of 0.98%.
Read our dividend analysis for RELX.

What other stocks do shareholders of Relx own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Relx investors own include Intel (INTC), NVIDIA (NVDA), Alibaba Group (BABA), JPMorgan Chase & Co. (JPM), Pfizer (PFE), Verizon Communications (VZ), AbbVie (ABBV), Walt Disney (DIS), International Business Machines (IBM) and McDonald's (MCD).

Who are Relx's major shareholders?

Relx's stock is owned by a number of retail and institutional investors. Top institutional investors include Capital International Investors (0.38%), Goldman Sachs Group Inc. (0.18%), Goldman Sachs Group Inc. (0.18%), Dimensional Fund Advisors LP (0.14%), Clearbridge Investments LLC (0.11%) and Envestnet Asset Management Inc. (0.09%).

How do I buy shares of Relx?

Shares of RELX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:RELX) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners